News for Innoviva, Inc. (INVA)

**media[631030]**

We recently published a list of 10 Stocks with Insanely High PE Ratios Insiders Are Selling. In this article, we are going to take a look at where Innoviva, Inc. (NASDAQ:INVA) stands against other stocks with insanely high PE ratios insiders are selling. The U.S. stock market has turned into a theater of extremes right […]

Transaction Overview On March 31, 2025, BlackRock, Inc. (Trades, Portfolio) executed a significant transaction involving Innoviva Inc (INVA), a company operatin

U.S. stock futures were lower this morning, with the Dow futures falling more than 100 points on Tuesday. Shares of Excelerate Energy, Inc. EE fell sharply in ...

On March 13, 2025, Sarissa Capital Management LP (Trades, Portfolio) executed a significant transaction involving Innoviva Inc. The firm reduced its holdings by

PR NewswireLOS ANGELES, March 12, 2025 Proceeds to be used to continue to advance development of Armata's phage product candidates LOS ANGELES, March 12, 2

Summary Innoviva Inc (INVA), a diversified holding company with a focus on royalties and healthcare investments, announced that its CEO, Pavel Raifeld, will par

Robust royalty portfolio with strong partnerships and innovative healthcare assets.Expansion into critical care and infectious disease markets through strategi

On February 26, 2025, Innoviva Inc (INVA) released its 8-K filing, detailing its financial results for the fourth quarter and full year 2024. Innoviva Inc, a di

Innoviva Inc (INVA), a diversified holding company with a focus on royalties and healthcare investments, announced its financial results for the fourth quarter

Innoviva, Inc. (NASDAQ: INVA) (”œInnoviva” or the ”œCompany”), a diversified holding company with a core royalties portfolio, a leading critical care and

Innoviva's shift to specialty therapeutics is backed by strong financials and a robust pipeline. Read why INVA stock presents an asymmetric risk-reward profile.

On December 31, 2024, Franklin Resources Inc, a prominent investment firm, executed a significant transaction involving Innoviva Inc (INVA). The firm reduced it

ImaginAb, Inc. Innovative Biologics Technology platform acquired by Telix to enable Next-Generation Therapeutic Assets discovery

The major U.S. index futures are currently pointing to a higher open on Monday, with stocks likely to see initial strength following the lackluster performance seen during last Friday's session.

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Innoviva Inc (INVA), through its subsidiary Innoviva Specialty Therapeutics, Inc. (IST), has announced an exclusive distribution and license agreement with Basi

Innoviva Specialty Therapeutics, Inc., (”œIST”) a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced it has entered into an exclusive distribution

**media[493017]**